Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 2Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Dermatologic 1

Conditions

Prostatic Neoplasms 19Breast Neoplasms 12Lung Neoplasms 10Brain Neoplasms 9Glioblastoma 7Neoplasm Metastasis 6Neoplasms 5Glioma 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Sarcoma 4Pancreatic Neoplasms 4Head and Neck Neoplasms 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Mycosis Fungoides 3Lymphoma, Non-Hodgkin 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, B-Cell, Marginal Zone 3Liver Neoplasms 3Gliosarcoma 3Waldenstrom Macroglobulinemia 2Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Sezary Syndrome 2Rectal Neoplasms 2Ovarian Neoplasms 2Oligodendroglioma 2Neuroendocrine Tumors 2

Interventions

Rituximab 24Cyclophosphamide 10fludarabine phosphate 8Bortezomib 7Lenalidomide 6Tacrolimus 5Mycophenolic Acid 5idelalisib 4ibrutinib 4Peripheral Blood Stem Cell Transplantation 4Antilymphocyte Serum 4tanespimycin 3Whole-Body Irradiation 3Radiotherapy 3Indium 3Dasatinib 3Cyclosporine 3pomalidomide 2ofatumumab 2nelarabine 2ibritumomab tiuxetan 2Vincristine 2Sirolimus 2Radiation 2Prednisone 2Polymerase Chain Reaction 2Methotrexate 2Melphalan 2Magnetic Resonance Spectroscopy 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Waldenstrom Macroglobulinemia × Magnetic Resonance Spectroscopy × Clear all
NCT00088881 2017-05-25

Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Terminated
62 enrolled 8 charts
Lymphoid

Waldenstrom Macroglobulinemia, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

NCT00504205 2013-08-02

MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma

National Cancer Institute (NCI)

Phase NA Terminated
30 enrolled
DermatologicLymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡